Zusätzliche Informationen (Öffentlich): | CAN 65:50925
68
Pharmacodynamics
872-44-6 (Pyrrolidinium, 1,1-dimethyl-, iodide); 1017-56-7 (Methanol, (s-triazine-2,4,6-triyltriimino)tri-); 1952-37-0 (Ethanol, 2-[(p-hydroxybenzylidene)amino]-); 2037-00-5 (Methanol, (diethylamino)-, acetate (ester); 3089-11-0 (Melamine, hexakis(methoxymethyl)-); 3275-13-6 (Piperidine, 1-(ethoxymethyl)-); 5752-37-4 (Melamine, hexakis[(ethylthio)methyl]-); 5752-43-2 (Ethylenediamine, N,N,N',N'-tetrakis[(ethylthio)methyl]-); 5766-67-6 (Acetonitrile, (ethylenedinitrilo)tetra-); 5766-68-7 (Glycinonitrile, N,N'-ethylenebis[N-methyl-); 5766-69-8 (Glycinonitrile, N,N'-(6-chloro-s-triazine-2,4-diyl)di-); 5766-70-1 (Glycinonitrile, N,N'-(6-amino-s-triazine-2,4-diyl)di-); 5766-74-5 (Phenol, p-(N-methylformimidoyl)-); 5766-75-6 (Pyrocatechol, 4-(N-methylformimidoyl)-); 5766-76-7 (Anthranilic acid, N-benzylidene-); 5766-79-0 (1-Piperidineacetonitrile, alpha -phenyl-); 13046-06-5 (Methanesulfonic acid, (s-triazine-2,4,6-triyltriimino)tri-, trisodium salt); 13046-10-1 (Methanesulfonic acid, (ethylenedinitrilo)tetra-, tetrasodium salt); 14451-14-0 (Methanesulfonic acid, [(ethylenebis(methylimino)di-, disodium salt) (neoplasm inhibition and); 51-46-7 (1,3,6,8-Tetraazatricyclo[4.4.1.13,8]dodecane); 51-80-9 (Methanediamine, N,N,N',N'-tetramethyl-); 51-82-1 (Carbamic acid, dimethyldithio-, (dimethylamino)methyl ester); 51-82-1 (Methanethiol, (dimethylamino)-, dimethyldithiocarbamate); 4082-71-7 (Imidazolidine, 1,3-bis[(ethylthio)methyl]-, dihydrochloride); 4135-86-8 (Ethylenediamine, N,N'-bis[(ethylthio)methyl]-N,N'-dimethyl-, dihydrochloride) (neoplasm inhibition by) |
---|